Gizmodo

The newest weight loss drug on the market, Zepbound, might also help keep people’s snoring down.

Gizmodo

The results of a nine-month investigation by health regulators in the European Union should be comforting for anyone taking Ozempic and other similar drugs to treat type 2 diabetes and/or obesity. EU officials said Friday that they failed to find evidence of a causative link between GLP-1 drugs and an increased risk…

Read more...

Gizmodo

New research might help you make the most of your exercising: Scientists tracked the long-term health of people living with obesity and found that those who exercised in the evening were the least likely to experience cardiovascular problems or to die compared to non-exercisers and those who exercised at other times.

Read more...

Gizmodo

The cost of Wegovy will soon be covered by Medicare, according to an announcement from the federal health insurance program for seniors on

Tech Insider : Economy, Economy
A close up view of a person injecting medication via an injector pen into the skin of their stomach
Weight-loss drugs could become a game-changer for the global economy, according to Capital Economics.
Gizmodo

Veterinary scientists seem to have unraveled a mystery about why certain dogs simply can’t ever get enough to eat. In research out this week, they found evidence that a common mutation in Labrador retrievers causes them to experience greater hunger than usual while also reducing their metabolic rate, both of which…

Read more...

Gizmodo

A lifetime of snacking and frozen food dinners may affect your body in lots of surprising ways, new research suggests. The study, a large-scale review of the existing evidence, found an association between regularly eating ultra-processed foods and a higher risk of many health problems. It also found that these foods…

Read more...

Gizmodo

The newest obesity drug on the market, Eli Lilly’s tirzepatide, may also help keep people’s blood pressure in check, new research out Monday has shown. The study looked at clinical trial participants and found that people taking it experienced a drop in their systolic blood pressure on average compared to a placebo…

Read more...

Gizmodo

A popular class of weight loss drugs may offer more lasting success than assumed, new data from Epic Research suggests. The study of medical records found that a slight majority of people who took GLP-1 drugs like semaglutide either maintained or improved their weight loss in the year after they stopped using the…

Read more...

Tech Insider
Renee Rayburg, vice president of specialty clinical consulting at Pharmaceutical Strategies Group
Renee Rayburg, vice president of specialty clinical consulting at Pharmaceutical Strategies Group